CYNTHIA NASH: Open Payments
NPI 1699273672 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 41 payments from 7 companies in 2025. Trend: 2023 $301 · 2024 $233 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $302 |
| Alkermes, Inc. | 4 | $87 |
| Indivior Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, SUBLOCADE, CAPLYTA, VIVITROL, ARISTADA, REXULTI, UZEDY, Qelbree.
Industry payments across MD — which companies pay providers there.
